Skip to main content
. 2018 Aug 24;8:12776. doi: 10.1038/s41598-018-30692-3

Figure 7.

Figure 7

Pictorial Abstract. A schematic summary showing how nuclosamide through the dysregulation of the Wnt/β-catenin signaling pathway, inhibits the stemness of OSCC cells via the downregulation of pluripotency transcription factors, suppress oral CSC -associated EMT and metastasis by upregulating vimentin and snail, while downregulating E-cadherin, as well as limit EMT-related extracellular matrix (ECM) remodeling by modulation of TIMP2, MMP2 and MMP9. Similarly, nuclosamide suppresses the cisplatin-induced oral CSC enrichment and enhances the sensitivity of the ALDH+ OSCC cells to cisplatin.